Physician's Desk Reference에 나타난 성별차이 분석
Analysis of Gender Differences in Physician’s Desk Reference
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: This study aims to investigate how gender-based differences are actually reflected on drug approval. Methods: Data on gender-based differences of drugs were analyzed by searching PDR (Physician’s Desk Reference) with the keyword, “GENDER”. Results: There were descriptions related to gender in product directions of 361 drugs in 2009 PDR, out of which 63items actually showed gender-related differences. Drug categories showing comparatively high gender-based differences were nervous system, cardiovascular system, and alimentary tract and metabolism. Pharmacokinetic differences between genders were observed most frequently; compared to men, 32 drugs showed higher absorption while 18 drugs revealed lower clearance in women. There were 2 drugs which gender should be considered before prescribing, and 5 drugs which showed different severity of adverse effects according to gender. Conclusions: It is necessary to establish domestic policies for drug approval and use which reflects gender-based differences through sufficient researches.
Abstract
Purpose: This study aims to investigate how gender-based differences are actually reflected on drug approval. Methods: Data on gender-based differences of drugs were analyzed by searching PDR (Physician’s Desk Reference) with the keyword, “GENDER”. Results: There were descriptions related to gender in product directions of 361 drugs in 2009 PDR, out of which 63items actually showed gender-related differences. Drug categories showing comparatively high gender-based differences were nervous system, cardiovascular system, and alimentary tract and metabolism. Pharmacokinetic differences between genders were observed most frequently; compared to men, 32 drugs showed higher absorption while 18 drugs revealed lower clearance in women. There were 2 drugs which gender should be considered before prescribing, and 5 drugs which showed different severity of adverse effects according to gender. Conclusions: It is necessary to establish domestic policies for drug approval and use which reflects gender-based differences through sufficient researches.
참고문헌 (20)
- Yang X, "Tissue-specific expression and regulation of sexually dimorphic genes in mice", Genome Res, 16, pp.995~1004 (2006)
- Pepine CJ, "Some thoughts on the vasculopathy of women with ischemic heart disease", J Am Coll Cardiol, 47, pp.S30~S35 (2006)
- "Society for Women's Health Research"[URL]
- "eNoteAlone"[URL]
- Ebert SN, "Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence", J Womens Health, 7, pp.547~557 (1998)
- 김현주, "의약품에서의 성별차이 및 유발요인", 한국임상약학회지, 20(2), pp.128~137 (2010), 한국임상약학회
- Cummins CL, "Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein", Clin Pharmacol Ther, 72, pp.474~489 (2002)
- "Protecting and Advancing Women's Health: The FDA Office of Women's Health Progress Peport 10 years and Beyond…, Mar. 2006" (2006)[URL]
- "Guideline for Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs, Jul. 1993"[URL]
- "Reflection Paper on Gender Differences in Cardiovascular Diseases, Dec. 2006"[URL]
- "PDR® 63edition 2009", ~
- Gail D, "Gender differences in pharmacological response", Int Rev Neuro, 83, pp.1~9 (2008)
- Fattinger K, "Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine", Br J Clin Pharmacol, 49, pp.158~167 (2000)
- Tran C, "Gender difference in adverse drug reactions", J Clin Pharmacol, 38, pp.1003~1009 (1998)
- Domecq C, "Sex-related variations in the frequency and characteristics of adverse drug reactions", Int J Clin Pharmacol Ther, 18, pp.362~366 (1980)
- Mojaverian P, "Effect of Food on the absorption of enteric coated aspirin: Correlation with gastric residence time", Clin Pharmacol Ther, 41, pp.11~17 (1987)
- Anderson G, "Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, and pharmacokinetics, and pharmacodynamics", J Womens Health, 14, pp.19~29 (2005)
- Gross J, "Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA", Braz J Med Biol Res, 25, pp.129~134 (1992)
- Drici M, "Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome", Drug Saf, 24, pp.575~585 (2001)
- Buckwalter J, "The disproportionate impact of chronic arthralgia and arthritis among women", Clin Orthop Relat Res, 372, pp.159~168 (2000)